secwatch.observer — SEC 8-K summary
======================================

Issuer:     ROCKWELL MEDICAL, INC. (RMTI)
CIK:        0001041024
Form:       8-K
Filed at:   2026-08-13T10:14:04+00:00
Accession:  0001628280-26-056454
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rockwell Medical Q2 net sales up 11% to $17.8M; net loss narrows to $1.2M
-------------------------------------------------------------------------

- Net sales $17.8M, +11% YoY; gross profit $3.2M, +30%; gross margin 18% vs 16%.
- Net loss $1.2M vs $1.5M loss; adjusted EBITDA -$0.2M; cash $24.8M at June 30.
- Reiterates 2026 guidance: net sales $70-75M, gross margin 18-22%, adj EBITDA $1-2M.
- 1-for-10 reverse stock split effective July 1, 2026; regained Nasdaq compliance.
- New/expanded agreements with Heritage Dialysis and aQua Dialysis during Q2.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1041024/000162828026056454/0001628280-26-056454-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1041024/000162828026056454/rmti-20260813.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-056454

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer